Lv5
1348 积分 2025-08-29 加入
Design and biological evaluation of novel long-acting adalimumab Fab conjugated with the albumin binding domain
1天前
已完结
Fusion to a highly stable consensus albumin binding domain allows for tunable pharmacokinetics
2天前
已完结
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
4天前
已完结
Antibody Engineering for Receptor-Mediated Transcytosis Across the Blood–Brain Barrier
4天前
已完结
Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial
4天前
已完结
Nano-DSF Technology as a Preliminary Decision-Making Tool for Long Term Stability Evaluation of Covid-19 Vaccine Antigens
16天前
已完结
First-in-class blood–brain barrier shuttle wins FDA nod for Hunter syndrome
22天前
已完结
Bioconjugates for improved delivery of oligonucleotide therapeutics to the central nervous system
29天前
已完结
An industry perspective on hyaluronidase co-formulated biopharmaceutics
1个月前
已完结
POS1049 SAFETY, TOLERABILITY, AND EFFICACY OF EMPASIPRUBART IN ADULTS WITH DERMATOMYOSITIS (EMPACIFIC): A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY
1个月前
已完结
皖公网安备34019202002308
